These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17452435

  • 1. Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.
    Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S.
    Protein Eng Des Sel; 2007 Apr; 20(4):189-99. PubMed ID: 17452435
    [Abstract] [Full Text] [Related]

  • 2. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M, Orlova A, Johansson E, Eriksson TL, Höidén-Guthenberg I, Tolmachev V, Nilsson FY, Ståhl S.
    J Mol Biol; 2008 Mar 07; 376(5):1388-402. PubMed ID: 18207161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
    Jonsson A, Wållberg H, Herne N, Ståhl S, Frejd FY.
    Biotechnol Appl Biochem; 2009 Aug 17; 54(2):93-103. PubMed ID: 19545237
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
    Lundberg E, Brismar H, Gräslund T.
    Biotechnol Appl Biochem; 2009 Jan 17; 52(Pt 1):17-27. PubMed ID: 18260830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo.
    Lindborg M, Cortez E, Höidén-Guthenberg I, Gunneriusson E, von Hage E, Syud F, Morrison M, Abrahmsén L, Herne N, Pietras K, Frejd FY.
    J Mol Biol; 2011 Mar 25; 407(2):298-315. PubMed ID: 21277312
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
    Nordberg E, Friedman M, Göstring L, Adams GP, Brismar H, Nilsson FY, Ståhl S, Glimelius B, Carlsson J.
    Nucl Med Biol; 2007 Aug 25; 34(6):609-18. PubMed ID: 17707800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain.
    Vernet E, Lundberg E, Friedman M, Rigamonti N, Klausing S, Nygren PA, Gräslund T.
    N Biotechnol; 2009 Sep 25; 25(6):417-23. PubMed ID: 19552886
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.
    Mume E, Orlova A, Larsson B, Nilsson AS, Nilsson FY, Sjöberg S, Tolmachev V.
    Bioconjug Chem; 2005 Sep 25; 16(6):1547-55. PubMed ID: 16287254
    [Abstract] [Full Text] [Related]

  • 18. Affibody-mediated transferrin depletion for proteomics applications.
    Grönwall C, Sjöberg A, Ramström M, Höidén-Guthenberg I, Hober S, Jonasson P, Ståhl S.
    Biotechnol J; 2007 Nov 25; 2(11):1389-98. PubMed ID: 17639529
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Engineered affinity proteins for tumour-targeting applications.
    Friedman M, Ståhl S.
    Biotechnol Appl Biochem; 2009 May 25; 53(Pt 1):1-29. PubMed ID: 19341363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.